namilumab (MT203)
M1-1188-002-EM
Phase 1 small_molecule completed
Quick answer
namilumab (MT203) for Rheumatoid Arthritis is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed